Compare R & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | R | SNN |
|---|---|---|
| Founded | 1933 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Rental/Leasing Companies | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.6B | 12.3B |
| IPO Year | 1994 | 2002 |
| Metric | R | SNN |
|---|---|---|
| Price | $238.29 | $27.24 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 6 |
| Target Price | ★ $288.33 | $32.32 |
| AVG Volume (30 Days) | 207.4K | ★ 1.2M |
| Earning Date | 10-22-2026 | 08-04-2026 |
| Dividend Yield | 1.72% | ★ 2.83% |
| EPS Growth | ★ 7.96 | N/A |
| EPS | ★ 5.71 | N/A |
| Revenue | ★ $12,665,000,000.00 | N/A |
| Revenue This Year | $4.88 | $4.91 |
| Revenue Next Year | $5.10 | $5.26 |
| P/E Ratio | ★ $41.19 | $64.97 |
| Revenue Growth | ★ 0.23 | N/A |
| 52 Week Low | $157.77 | $26.38 |
| 52 Week High | $284.25 | $37.51 |
| Indicator | R | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 48.57 | 45.23 |
| Support Level | $224.11 | $26.30 |
| Resistance Level | $250.96 | $31.36 |
| Average True Range (ATR) | 5.04 | 0.40 |
| MACD | 0.95 | 0.10 |
| Stochastic Oscillator | 81.65 | 60.59 |
Ryder System Inc operates in three business segments: (1) Fleet Management Solutions which provides full-service leasing and leasing with flexible maintenance options, commercial rental and maintenance services of trucks, tractors and trailers to customers; (2) Supply Chain Solutions (SCS), which provides integrated logistics solutions, including distribution management, dedicated transportation, transportation management, brokerage, e-commerce, last mile, and professional services; and (3) Dedicated Transportation Solutions (DTS), which provides turnkey transportation solutions in the U.S., including dedicated vehicles, professional drivers, management, and administrative support.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 40% of the UK-based firm's revenue comes from orthopedic products, and another 31% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the US, just over 30% is from other developed markets, and emerging markets account for the remainder.